Minor hallucinations occur in drug‐naive Parkinson's disease patients, even from the premotor phase

Cited by (237)

Items 101–200 of 237

1. Functional Brain Networks of Minor and Well‐Structured Major Hallucinations in Parkinson's Disease
   Kyoungwon Baik, Yae Ji Kim, Mincheol Park, Seok Jong Chung, Young H. Sohn, Yong Jeong, Phil Hyu Lee · 2023 · Movement Disorders
2. Aberrant gray matter volume and functional connectivity in Parkinson’s disease with minor hallucination
   Min Zhong, Chenglin Li, Hongquan Lu, Donghui Xue, Yaxi Wang, Yinyin Jiang, Sha Zhu, Ruxin Gu, Xu Jiang, Bo Shen et al. · 2022 · Frontiers in Aging Neuroscience
3. Elevation of Plasma Homocysteine and Minor Hallucinations in Parkinson’s Disease: A Cross-Sectional Study
   Min Zhong, Sha Zhu, Ruxin Gu, Yaxi Wang, Yinyin Jiang, Yu Bai, Xu Jiang, Bo Shen, Jun Yan, Yang Pan et al. · 2022 · Behavioural Neurology
4. Visual hallucinations
   Rimona Sharon Weil, Andrew John Lees · 2021 · Practical Neurology
5. A systematic review on resting state functional connectivity in patients with neurodegenerative disease and hallucinations
   Vittoria Spinosa, Elvira Brattico, Fulvia Francesca Campo, Giancarlo Logroscino · 2022 · NeuroImage Clinical
6. On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson’s Disease Psychosis
   Fernando Pagán, Paul Ernest Schulz, Yasar A. Torres-Yaghi, Gregory M. Pontone · 2024 · CNS Drugs
7. Minor Hallucinations in Alzheimer’s Disease
   María Belén Anda Ruiz, Alfonso Martínez Arias, Ernesto Sánchez-Llanos, María Pilar Gil, Ricard López Ortega, Farida Dakterzada, Francisco F. Purroy, Gerard Piñol‐Ripoll · 2018 · Journal of Alzheimer s Disease
8. Cognitive and behavioral assessment in Parkinson’s disease
   Saül Martínez‐Horta, Andrea Horta‐Barba, Jaime Kulisevsky · 2019 · Expert Review of Neurotherapeutics
9. Evidence From Parkinson's Disease That the Superior Colliculus Couples Action and Perception
   Elena Pretegiani, Nora Vanegas‐Arroyave, Edmond J. FitzGibbon, Mark Hallett, Lance M. Optican · 2019 · Movement Disorders
10. Shared and distinct cortical morphometric alterations in five neuropsychiatric symptoms of Parkinson’s disease
    Qianling Lu, Zhuang Zhu, Heng Zhang, Caiting Gan, Aidi Shan, Mengxi Gao, Huimin Sun, Xingyue Cao, Yongsheng Yuan, Joseph I. Tracy et al. · 2024 · Translational Psychiatry
11. Psychiatric and cognitive symptoms of Parkinson's disease: A life's tale
    Deborah Amstutz, Mário Sousa, Marie Elise Maradan‐Gachet, Ines Debove, Eugénie Lhommée, Paul Krack · 2024 · Revue Neurologique
12. QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson’s Disease Psychosis: A Narrative Review
    Yasar A. Torres-Yaghi, Amelia Carwin, Jacob Carolan, Steven Nakano, Fahd Amjad, Fernando Pagán · 2021 · DOAJ (DOAJ: Directory of Open Access Journals)
13. Minor hallucinations in isolated rapid eye movement sleep behavior disorder indicative of early phenoconversion: A preliminary study
    Yukiyoshi Sumi, Ayaka Ubara, Yuji Ozeki, Hiroshi Kadotani · 2021 · Acta Neurologica Scandinavica
14. Clinical Characteristics of Minor Hallucinations in Chinese Parkinson's Disease Patients
    Yu Zhang, Guo yong Zhang, Xiao bo Zhu, Zi en Zhang, Jing Gan, Zhen guo Liu · 2022 · Frontiers in Aging Neuroscience
15. Psychosis
    Parunyou Julayanont, Uma Suryadevara · 2021 · CONTINUUM Lifelong Learning in Neurology
16. RNA-seq analysis of gene expression profiles in posttraumatic stress disorder, Parkinson’s disease and schizophrenia identifies roles for common and distinct biological pathways
    Sian M. J. Hemmings, Patricia Swart, Jacqueline Samantha Womersley, Ellen S. Ovenden, Leigh L. van den Heuvel, Nathaniel W. McGregor, Stuart Meier, Soraya Bardien, Shameemah Abrahams, Gerard C. Tromp et al. · 2022 · Discover Mental Health
17. Minor Phenomena in Parkinson’s Disease–Prevalence, Associations, and Risk of Developing Psychosis
    Ruth B. Schneider, Peggy Auinger, Roseanne D. Dobkin, Kelly A. Mills, Catherine V. Kulick‐Soper, Taylor L. Myers, Monica Korell, Gregory M. Pontone, Melissa Jill Nirenberg · 2023 · Journal of Geriatric Psychiatry and Neurology
18. Late life psychotic features in prodromal Parkinson's disease
    Ioanna Pachi, Maria I. Maraki, Nikolaos Giagkou, Mary H. Kosmidis, Mary Yannakoulia, Efthimios Dardiotis, Georgios M. Hadjigeorgiou, Paraskevi Sakka, Eva Ntanasi, Georgia Xiromerisiou et al. · 2021 · Parkinsonism & Related Disorders
19. Psychosis in Parkinson’s Disease: Looking Beyond Dopaminergic Treatments
    Milagros Rojas, Mervin Chávez-Castillo, Pablo Durán, Ángel Ortega, María Judith Bautista-Sandoval, Juan José Salazar, Manuel Riaño-Garzón, Maricarmen Chacín, Óscar Medina, Jim Palmar et al. · 2022 · Current Pharmaceutical Design
20. Non-visual hallucinations in Parkinson’s disease: a systematic review
    Wei Lin Toh, Caitlin O. B. Yolland, Caroline Gurvich, James Barnes, Susan Lee Rossell · 2023 · Journal of Neurology
21. Progress Regarding Parkinson's Disease Psychosis: It's No Illusion
    Daniel A. Weintraub · 2016 · Movement Disorders Clinical Practice
22. Approaches for treating neuropsychiatric symptoms in Parkinson’s disease: a narrative review
    Jon Rodríguez-Antigüedad, Gonzalo Olmedo‐Saura, Javier Pagonabarraga, Saül Martínez‐Horta, Jaime Kulisevsky · 2025 · Therapeutic Advances in Neurological Disorders
23. Age-Dependent Neuropsychiatric Symptoms in the NF-κB/c-Rel Knockout Mouse Model of Parkinson’s Disease
    Edoardo Parrella, Federico Del Gallo, Vanessa Porrini, Cristina Gussago, Marina Benarese, Paolo Francesco Fabene, Marina Pizzi · 2022 · Frontiers in Behavioral Neuroscience
24. Affective Correlates of Psychosis in Parkinson's Disease
    Stewart Alan Factor, Michael K. Scullin, Alan Freeman, Donald L. Bliwise, William Maffitt McDonald, Felicia C. Goldstein · 2016 · Movement Disorders Clinical Practice
25. Changing the treatment paradigm for Parkinson’s disease psychosis with pimavanserin
    Kelly E. Lyons, Rajesh Pahwa, Neal S. Hermanowicz, Thomas L. Davis, Fernando Pagán, Stuart Isaacson · 2019 · Expert Review of Clinical Pharmacology
26. Plasma Neurofilament Light and p-tau181 and Risk of Psychosis in Parkinson’s Disease
    Lucy L. Gibson, Thomas Arthur Pollak, Amanda Heslegrave, Abdul Hye, Lucia Batzu, Silvia Rota, Dhaval Trivedi, Timothy R. Nicholson, Dominic H Ffytche, Henrik Zetterberg et al. · 2022 · Journal of Parkinson s Disease
27. Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson’s Disease: What Do Clinical and Neuroimaging Studies Tell Us?
    Alexandru Hanganu, Oury Monchi · 2018 · Current Neurology and Neuroscience Reports
28. 5-HT3 receptors in Parkinson's disease psychosis: a forgotten target?
    Cynthia Kwan, P. Huot · 2019 · Neurodegenerative Disease Management
29. Incidence of antipsychotic use among community dwellers with and without Parkinson's disease
    Satu Lilja, Anna‐Maija Tolppanen, Marjaana Koponen, Sirpa A. Hartikainen, Miia Tiihonen · 2022 · Parkinsonism & Related Disorders
30. Dopamine and Functional Connectivity in Patients With Parkinson's Disease and Visual Hallucinations
    Alice Powell, Alana J. Muller, Claire O’Callaghan, Marion Sourty, James M. Shine, Simon J.G. Lewis · 2020 · Movement Disorders
31. The role of attentional control over interference in minor hallucinations in Parkinson’s disease
    Helena Bejr‐Kasem, Saül Martínez‐Horta, Javier Pagonabarraga, Juan Marín‐Lahoz, Andrea Horta‐Barba, Frederic Sampedro, Ignacio Aracil‐Bolaños, Jesús Pérez‐Pérez, Antònia Campolongo, Cristina Izquierdo et al. · 2022 · Parkinsonism & Related Disorders
32. Parkinson’s disease psychosis management: an evidence based, experience informed, pragmatic approach
    Joseph H. Friedman · 2024 · Expert Opinion on Pharmacotherapy
33. Vision loss and hallucinations: perspectives from neurology and ophthalmology
    Ali G. Hamedani · 2020 · Current Opinion in Neurology
34. Phantosmia in Parkinson’s Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations
    Tommaso Ercoli, Caterina Bagella, Claudia Frau, Elisa Ruiu, Sabrine Othmani, Giansalvo Gusinu, Carla Masala, Leonardo Antonio Sechi, Paolo Solla, Giovanni Defazio · 2023 · Neurology International
35. Factor structure and age invariance of the Cardiff Anomalous Perceptions Scale (CAPS) in healthy older and younger adults.
    India Kelsall-Foreman, Brandon E. Gavett, Romola Starr Bucks, Michael Weinborn, Johanna Claire Badcock · 2020 · Psychological Assessment
36. Clinical features of minor hallucinations in different phenotypes of Parkinson’s disease: A cross-sectional study
    Yaxi Wang, Dongfeng Li, Yaning Chen, Sha Zhu, Xu Jiang, Yinyin Jiang, Ruxin Gu, Bo Shen, Jun Zhu, Yang Pan et al. · 2023 · Frontiers in Neurology
37. Minor hallucinations in Parkinson’s disease with probable rapid eye movement sleep behavior disorder
    Yinyin Jiang, Jun Zhu, Yang Zhao, Dongfeng Li, Yaning Chen, Yaxi Wang, Xu Jiang, Bo Shen, Yang Pan, Jun Yan et al. · 2023 · Frontiers in Neuroscience
38. Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease
    Ioanna Pachi, Vassilis Papadopoulos, Christos Koros, Athina‐Maria Simitsi, Anastasia M. Bougea, Maria Bozi, Nikolaos Papagiannakis, Rigas Filippos Soldatos, Dimitra Kolovou, George V. Pantes et al. · 2023 · Journal of Parkinson s Disease
39. Editorial on: Pagonabarraga J, Martinez‐Hora S, Fernandez de Bobadilla R et al. Minor hallucinations occur in drug‐naïve Parkinson's disease patients even from the premotor phase. Movement Disorders 2015; Available from: DOI: 10.1002/mds.26432
    Joseph H. Friedman · 2015 · Movement Disorders
40. Connectome-based brain fingerprints predict early cognitive decline in Parkinson’s patients with minor hallucinations
    Stampacchia, Sara, Bernasconi, Fosco, Van De Ville, Dimitri, Amico, Enrico, Pagonabarraga, Javier, Kulisevsky, Jaime, Blanke, Olaf · 2025
41. Real-time fMRI neurofeedback modulates induced hallucinations and underlying brain mechanisms
    Herberto Dhanis, Nicolas Gninenko, Elenor Morgenroth, Jevita Potheegadoo, Giulio Rognini, Nathan Faivre, Olaf Blanke, Dimitri Van De Ville · 2024 · Communications Biology
42. Where do PDD and DLB SYNdromes fit in neuronal alpha-SYNuclein biological frameworks?
    David John Irwin · 2025 · Journal of Neural Transmission
43. Sleep-related hallucinations in patients with Parkinson’s disease
    Tomoko Komagamine, Keisuke Suzuki, Norito Kokubun, Junpei Komagamine, Akiko Kawasaki, Kei Funakoshi, Koichi Hirata · 2022 · PLoS ONE
44. Creativity and Parkinson’s Disease
    Marie Elise Maradan‐Gachet, Ines Debove, Eugénie Lhommée, Paul Krack · 2023 · Current clinical neurology
45. CBT for psychosis in Parkinson's disease: A framework for how and why
    Jennifer A. Foley, Vaughan Bell · 2025 · Schizophrenia Research
46. Parkinson's Disease With Visual Hallucinations Is Associated With Epileptiform Activity on EEG
    Adam Fry, Dharampreet Singh, Louis N. Manganas, Marc L. Gordon, Christopher Christodoulou, Hoi‐Chung Leung, Guy J. Schwartz · 2022 · Frontiers in Neurology
47. A New Definition of Psychosis Is Needed in Parkinson's Disease
    Joseph H. Friedman · 2024 · Movement Disorders
48. Clinical and cognitive features associated with psychosis in Parkinson's disease: a longitudinal study
    Joseph L. Flanigan, Madaline B. Harrison, James T. Patrie, Binit Shah, Scott A. Sperling, Kathryn A Wyman‐Chick, William Alexander Dalrymple, Matthew J. Barrett · 2024 · Frontiers in Aging Neuroscience
49. Trends and Contributing Factors for Prescribing Antipsychotics in Newly Diagnosed Parkinson’s Disease Patients: A Population-Based Study
    Khalid Mubarak Orayj · 2021 · Risk Management and Healthcare Policy
50. Exploring the Spectrum of Visual Illusions and Other Minor Hallucinations in Patients with Parkinson’s Disease in Lithuania
    Neringa Jucevičiūtė, Renata Balnytė, Ovidijus Laucius · 2024 · Medicina
51. Being a Scientist–Practitioner in the Field of Psychosis: Experiences From Voices Clinics
    Geòrgie Paulik, Neil Thomas, Evie Glasshouse, Mark Hayward · 2019 · Elsevier eBooks
52. Clinical and Functional Connectivity Markers in Prediction of Hallucinations in Parkinson's Disease
    Guanglu Li, Mengxue Jiang, Xin Chen, Panpan Hu, Jun Liu, Kai Wang · 2025 · CNS Neuroscience & Therapeutics
53. Neuropsychiatric features of Parkinson's disease in the era prior to the use of dopaminergic therapies
    Chengyu Zhang, Suzanne Reeves, Anthony S. David, Harry Costello, Jonathan P. Rogers · 2023 · Cognitive Neuropsychiatry
54. Psychosis in Parkinson’s Disease and Current Management Trends- an Updated Review of Literature
    Rajib Dutta · 2023 · Journal of Neuroscience and Neurological Disorders
55. Ursachen visueller Halluzinationen bei der Parkinson-Krankheit
    Nico J. Diederich · 2021 · Der Nervenarzt
56. Investigation of the Pharmaceutical Care in One Elderly Parkinson’s Disease Patient with Psychotic Symptoms
    Chunping Gu, Yueliang Xie, Yin-Juan Liao, Cuifang Wu, Shengfeng Wang, Yulu Zhou, Sujie Jia · 2018 · Drug Safety - Case Reports
57. Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs
    Evita Papathoma, Panagiota Tsitsi, Nirosen Vijiaratnam, Camila Aquino, Stephen R. Duma, Norbert Kovács, Kigocha Okeng’o, Aparna Wagle Shukla, Roongroj Bhidayasiri, Tiago Mestre et al. · 2025 · Movement Disorders Clinical Practice
58. Neuroimaging Advances in Neuropsychiatric Symptoms Associated with Parkinson’s Disease
    Qirui Zhang, Jacqueline I. Kim, Qianling Lu · 2025 · Brain Conflux
59. Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases
    Nathan H. Heller, Frederick Streeter Barrett, Tobias Buchborn, Daniel Collerton, David Dupuis, Adam L. Halberstadt, Renaud Jardri, Tehseen N. Noorani, Katrin H. Preller, John‐Paul Taylor et al. · 2025 · Schizophrenia Bulletin
60. The Emerging Role of Pimavanserin in the Management of Parkinson’s Disease Psychosis
    Neal S. Hermanowicz, Gustavo Alva, Fernando Pagán, Alberto Javier Espay, Amita Patel, Katya Cruz Madrid, Daniel E. Kremens, Jim Kenney, Sheila M. Arquette, Gary J. Tereso et al. · 2017 · Journal of Managed Care & Specialty Pharmacy
61. Feeling of a presence and anomalous body perception
    Masayuki Hara, Olaf Blanke, Noriaki Kanayama · 2021
62. Association of the number of minor hallucinations and well-structured visual hallucinations in Parkinson’s disease
    Hai‐Ying Zhang, Yang Zhao, Yi Chen, Yuanyuan Feng, Bo Shen, Shuangshuang Dong, Jun Zhu, Xu Jiang, Dongfeng Li, Yaning Chen et al. · 2025 · npj Parkinson s Disease
63. Treatment Possibilities for Psychosis in Parkinson's Disease with An Emphasis on the Newly Approved Drug: Pimavanserin
    Zsófia Majláth, Izabella Obál, László Vécsei · 2016 · CNS & Neurological Disorders - Drug Targets
64. Parkinson’s Disease Psychosis – Prevalence Patterns Across the EU-5
    Keziah Cook, Rathi Suresh, Kai-Jye Lou, J. Patrick Kesslak, Doral Fredericks · 2017 · European Neurological Review
65. Clinical Updates and Recent Developments in Neuro-Ophthalmology
    Amrita-Amanda D. Vuppala, Neil R. Miller · 2019 · Springer eBooks
66. Cold flow model testing of the HYTORT process retort design
    R.C. Rex, J.C. Janka, Ted Merrill Knowlton · 1984 · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
67. Sensorimotor hallucinations in Parkinson’s disease
    Fosco Bernasconi, Eva Blondiaux, Jevita Potheegadoo, Giedre Stripeikyte, Javier Pagonabarraga, Helena Bejr‐Kasem, Michela Bassolino, Michel Akselrod, Saül Martínez‐Horta, Fred Sampedro et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
68. Digital-robotic markers for hallucinations in Parkinson’s disease
    Louis Albert, Jevita Potheegadoo, Bruno Herbelin, Fosco Bernasconi, Olaf Blanke · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
69. Parkinson’s Disease: An Overview of the Non-Motor Symptomatology
    Daniel J. van Wamelen, Valentina Leta, К. Ray Chaudhuri · 2022 · Cambridge University Press eBooks
70. Global research trends and hotspots in Parkinson’s disease psychosis: a 25-year bibliometric and visual analysis
    Jianhong Wu, Xin Jin, Weiming Xie, Liang Liu, Fei Wang, Ling Zhu, Yuan Shen, Linghe Qiu · 2024 · Frontiers in Aging Neuroscience
71. Neuropsychiatric symptoms in Parkinson’s disease: review of data from the Arab world
    A. Chabbouh, Hassan Khalil, C. Abboud, Antoine Sader, Rita Khoury · 2024 · Journal of International Medical Research
72. Long‐Term Outcomes in a Parkinson's Disease Minor Phenomena Cohort
    Ruth B. Schneider, Anisha Singh, Miriam T. Weber, Anneliese T. Elmer, Katherine Amodeo, Karlo J. Lizárraga, Irene Hegeman Richard, Michael McDermott · 2025 · Movement Disorders Clinical Practice
73. How Layer-Specific fMRI Can Contribute to Understanding Perceptual Disturbances Across Psychiatric Disorders
    Joost Haarsma, Peter Kok · 2025 · Current topics in behavioral neurosciences
74. Reduced susceptibility to experimentally-induced complex visual hallucinations with age
    Oris Shenyan, Laura Haye, Georgia A. Milne, Matteo Lisi, John A. Greenwood, Jeremy I Skipper, Tessa M. Dekker · 2025 · Cortex
75. Diagnosis: Warning signs
    Katherine Bourzac · 2016 · Nature
76. Halluzinationen bei Patienten mit idiopathischem Parkinson-Syndrom
    Daniel Weiß, Günter U. Höglinger, Fabian Klostermann, David Weise, Kirsten E. Zeuner, Heinz Reichmann · 2021 · Fortschritte der Neurologie · Psychiatrie
77. Parkinson’s disease progression and fronto-temporal disconnection relate to identity of minor hallucinations
    Neza Vehar, Jevita Potheegadoo, Nathalie Heidi Meyer, Lada Kohoutová, Lea Duong Phan Thanh, Cyrille Stucker, Marie Elise Maradan‐Gachet, Herberto Dhanis, Lucas Burget, Sara Stampacchia et al. · 2026 · npj Parkinson s Disease
78. Frontal subcortical executive dysfunction and minor hallucinations in Parkinson’s disease are linked to sensitivity to somatomotor conflicts
    Jevita Potheegadoo, Léa F. Duong Phan Thanh, Fosco Bernasconi, Nathalie Heidi Meyer, Laurent Jenni, Marie Elise Maradan‐Gachet, Cyrille Stucker, Sabina Catalano Chiuvé, Julien François Bally, Mayté Castro Jiménez et al. · 2025 · medRxiv
79. Sleep-like slow waves during wakefulness uncover a malignant form of Parkinson’s disease
    Fosco Bernasconi, Thomas Andrillon, Juan Carlos Farah, Isabelle Arnulf, Sophie Schwartz, Jevita Potheegadoo, Saül Martínez‐Horta, Javier Pagonabarraga, Jaime Kulisevsky, Olaf Blanke · 2025 · medRxiv
80. Cholinergic neurotransmission underlying visual hallucinations in Parkinson's disease: Integration of multimodal evidence and translational approaches
    Liu, Jinshuo, Yu, Dezhu, Liu, Yu, Yong, Yuxuan, Wang, Zihao, Fan, Peidong, Yang, Xinling · 2026 · Neurobiology of Disease
81. Comorbilidad neurológica en pacientes psiquiátricos ingresados: evidencia sobre interconsultas de neurología en un centro español
    Carlos Peña‐Salazar, Natalia Kazah Soneyra, Belén Carrillo, Carles Díaz, Antonio Callén, Antoni Serrano‐Blanco, Ignacio Aznar‐Lou · 2024 · Revista de Neurología
82. Buried Treasure? Overlooked and Newly Discovered Evolutionary Contributions to Human Brain Diseases
    Nico J. Diederich, Martin Brüne, John S. Allen, Nicole Bender, Emiliano Bruner, Jean‐Pierre Changeux, Corrado Calì, Olga Dolgova, Anne Grünewald, Geneviève Konopka et al. · 2025 · Annals of Neurology
83. Presence hallucination induction through robotically mediated somatomotor conflicts: A pooled analysis of 25 experiments
    Herberto Dhanis, Jevita Potheegadoo, Nathan Faivre, Masayuki Hara, Fosco Bernasconi, Olaf Blanke · 2026 · Cortex
84. Disrupted visual-to-semantic dynamics promote visual hallucinations in Parkinson’s disease
    Laura Pérez‐Carasol, Saül Martínez‐Horta, Andrea Horta‐Barba, Helena Bejr‐Kasem, Juan Marín‐Lahoz, Jesús Pérez‐Pérez, Ignacio Aracil‐Bolaños, Javier Pagonabarraga, Jaime Kulisevsky · 2025 · npj Parkinson s Disease
85. Frontal subcortical executive dysfunction and minor hallucinations in Parkinson's disease are linked to sensitivity to somatomotor conflicts
    Jevita Potheegadoo, Lea Duong Phan Thanh, Fosco Bernasconi, Nathalie Heidi Meyer, Laurent Jenni, Marie Elise Maradan‐Gachet, Cyrille Stucker, Herberto Dhanis, Sabina Catalano Chiuvé, Julien François Bally et al. · 2026 · Journal of Parkinson s Disease
86. Patient-specific functional networks track early cognitive alterations and minor hallucinations in Parkinson’s disease
    Sara Stampacchia, Fosco Bernasconi, Dimitri Van De Ville, Enrico Amico, Lada Kohoutová, John‐Paul Taylor, Alan J. Thomas, Javier Pagonabarraga, Jaime Kulisevsky, Olaf Blanke · 2026 · Nature Mental Health
87. Modern approaches to treatment of psychosis in Parkinson’s disease
    Vitalii Cozac · 2016 · S S Korsakov Journal of Neurology and Psychiatry
88. Knowledge domain and emerging trends in visual hallucination research: A scientometric analysis
    Min Zhong, Zhuang Wu, Xu Jiang, Bo Shen, Jun Zhu, Li Zhang · 2021 · World Journal of Psychiatry
89. Cas 5. Addictions comportementales et apathie dans la maladie de Parkinson : d’un extrême à l’autre
    Sabina Catalano Chiuvé, João Flores Alves dos Santos, P. Burkhard, P. Krack · 2018 · 13 cas cliniques en neuropsychologie des émotions
90. Psychotic disorders in Parkinson's disease: phenomenology, pathogenesis, therapeutic approaches (modern view on the problem)
    Kh. I. Alizade, A. A. Ragimova, E. Yu. Fedotova, Sergey Nikolaevich Illarioshkin · 2024 · Neurology neuropsychiatry Psychosomatics
91. Enhanced visual illusions in Parkinson’s disease with cardiovascular autonomic failure
    Tadashi Umehara, Masahiro Mimori, Tatsushi Kokubu, Masakazu Ozawa, Tomotaka Shiraishi, Asako Onda, Hiromasa Matsuno, Shusaku Omoto, Hidetomo Murakami, Yasuyuki Iguchi · 2025 · Clinical Autonomic Research
92. Pharmacotherapy of Psychosis in Parkinson’s Disease
    Cynthia Kwan, Imane Frouni, Philippe Huot · 2020 · Springer eBooks
93. Visual disturbances in Parkinson’s disease
    A. Yu. Nikitina, N. V. Mel’nikova, Larisa Konstantinovna Moshetova, Oleg Semenovich Levin · 2022 · S S Korsakov Journal of Neurology and Psychiatry
94. Pharmacotherapy of Psychosis in Parkinson’s Disease
    Cynthia Kwan, Imane Frouni, Philippe Huot · 2022 · Springer eBooks
95. Unusual early symptoms of Parkinson’s disease. Why do we need to identify them?
    Henrique Ballalai Ferraz, Carolina Candeias da Silva · 2016 · Arquivos de Neuro-Psiquiatria
96. Understanding How to Care about Indifference: A Multistep Approach to Apathy in Parkinson’s Disease
    Bria Mele · 2018 · Libraries and Cultural Resources (University of Calgary)
97. G-protein coupled receptor 88 knock-down in the associative striatum reduces the psychiatric symptoms in a translational model of Parkinson’s disease
    Benjamin Galet, Manuela Ingallinesi, Jonathan Pegon, Anh N. Do Thi, Philippe Ravassard, Nicole Faucon Biguet, Rolando Meloni · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
98. Letter to the editor: Is polygenic risk for Parkinson's disease associated with less risk of first episode psychosis?
    Diego Quattrone, Alexander L. Richards, Ulrich Reininghaus, Evangelos Vassos, Michael C. O’Donovan, Cathryn M. Lewis, Marta Di Forti · 2019 · Psychological Medicine
99. Deviations in effective connectivity explain different hallucination subtypes in Parkinson's disease psychosis
    Vignando, Miriam, Ffytche, Dominic, Mazibuko, Ndabezinhle, Palma, Giulio, Bhat, Anjali, Montagnese, Marcella, Dave, Sonali, Tai, Yen F., Batzu, Lucia, Leta, Valentina et al. · 2026 · Nature Mental Health
100. Neuropsiquiatría de los trastornos del movimiento
     Juan Manuel Orjuela-Rojas, Gustavo Barrios Vincos, Melisa Alejandra Martínez Gallego · 2017 · Revista Colombiana de Psiquiatría